Skip to main content
OpenTrials
Completed

NCT Number: NCT04731597

Drug Interactions and Hip Fracture Risk in Older Adults

Older people are in great risk of hip fracture for multiple reasons. Also they often are on medications for medical conditions. Hip fracture risk increases in relation to some medications. When older peoples take 2 or more medications they are in increase risk of hip fracture.

Completed

Looking for future studies?

Notify Me

Key information

Age range

64 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Italiano de Buenos Aires

CABA, Buenos Aires, 1199, Argentina

About this study

In this study the investigators describe medication intake profile and identify older people risk of hip fracture in relation to their medication when they are taken together.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Affiliated patients to the HMO Plan de Salud Hospital Italiano at least 6 months affiliated.

older than 64 years old

  • affiliated between 01/07/2014 al 31/12/2019.

Exclusion criteria

  • Pathological Hip fracture
  • bilateral elective hip replacement previous study period

Treatment and study plan

drug interaction

Drug

when two drugs are taken together

Primary outcomes

  1. hip fracture

    Time frame: 1 year

    non pathological hip fracture

Sponsors and collaborators

Lead sponsor

Hospital Italiano de Buenos Aires

Other

Registry information

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Feb 1, 2021
Registry last updated
Feb 2, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.